Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00804076 · ClinicalTrials.gov registry record · Phase 1
Gene Transfer for Cancer Pain
A Phase 1 study of Cancer Pain, sponsored by Diamyd.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 5
- Study locations
NCT00804076: Completed Phase 1 study of Cancer Pain, sponsored by Diamyd.
NCT00804076 is a Phase 1 study of Cancer Pain that has completed, run by Diamyd. The registered enrollment target is 10 participants, below the 162-participant average among 15 other Cancer Pain trials with a reported enrollment target (94% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00804076, a Phase 1 study of Cancer Pain, has completed, sponsored by Diamyd.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 5
- Study locations
Study Summary
The primary purpose of this study is to examine the safety of NP2 (a nonreplicating HSV-based vector expressing enkephalin) in patients with cancer pain. The secondary purpose is to evaluate efficacy.
Conditions Studied
Interventions
- BIOLOGICAL NP2
Study Locations (5)
Florida
- Advanced Pharma CR - Miami
Louisiana
- Louisiana Research Associates - New Orleans
Michigan
- University of Michigan Medical Center - Ann Arbor
North Carolina
- Center for Clinical Research - Winston-Salem
Oregon
- Pain Research of Oregon, LLC - Eugene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2008-02 |
| Est. Completion | 2013-07 |
| Phase | Phase 1 |
What the finished NCT00804076 record still lists
NCT00804076 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 162-participant average among 15 other Cancer Pain trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Cancer Pain appearing as the primary indexed condition, and to 1 intervention - of which NP2 is the first listed.
NCT00804076 lists 5 locations in 5 states (Florida, Louisiana, Michigan).
Frequently Asked Questions
What is clinical trial NCT00804076 about?
NCT00804076 is a clinical study titled "Gene Transfer for Cancer Pain". The primary purpose of this study is to examine the safety of NP2 (a nonreplicating HSV-based vector expressing enkephalin) in patients with cancer pain. The secondary purpose is to evaluate efficacy.
What is the current status of trial NCT00804076?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2008-02. Estimated completion is 2013-07.
What conditions does trial NCT00804076 study?
This clinical trial studies the following conditions: Cancer Pain.
What interventions are being tested in trial NCT00804076?
The interventions under investigation include: NP2 (BIOLOGICAL).
Who is sponsoring clinical trial NCT00804076?
This trial is sponsored by Diamyd, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00804076 being conducted?
This trial has 5 study locations across Florida, Louisiana, Michigan, North Carolina, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00804076's enrollment target sits among peer trials
10 16th of 15 the lowest of 15 other Cancer Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study Testing Topical Pain-Relieving Herbal Plasters in People Who Are Using Opioids for Their Pain
RECRUITING · Phase 1
-
Cognitive Behavioral Theory-assisted Virtual Reality for Chronic CANcer Pain (VR-CAN)
RECRUITING · NA
-
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
RECRUITING · NA
-
Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy
RECRUITING · NA
-
Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement
RECRUITING · NA
-
Cancer Pain Management Using a Web-based Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia